Shanghai Haohai Biological Technology Co., Ltd. (FRA:5HB)

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Medical Aesthetics and Wound Care	1.06B
Medical Aesthetics and Wound Care Growth	41.90%
Ophthalmic	928.21M
Ophthalmic Growth	20.57%
Orthopedic	476.09M
Orthopedic Growth	22.56%
Anti-Adhesion and Hemostatic	141.76M
Anti-Adhesion and Hemostatic Growth	-19.98%
Other	46.39M
Other Growth	-0.54%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	2.20B
China Growth	27.52%
Other Countries	196.77M
Other Countries Growth	23.11%
Europe	136.05M
Europe Growth	-3.38%
United States	120.28M
United States Growth	15.97%